Page last updated: 2024-09-04

moxifloxacin and cefuroxime axetil

moxifloxacin has been researched along with cefuroxime axetil in 5 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(cefuroxime axetil)
Trials
(cefuroxime axetil)
Recent Studies (post-2010) (cefuroxime axetil)
3,1575521,69033013330

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke, T; Church, D; Haverstock, D; Heyd, A; Huck, W; Mariano, H; Orchard, D; Villanueva, C1
Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B1
Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R1
Barth, J; Beckmann, H; Höffken, G; Rubinstein, E1
Ruef, C1

Trials

4 trial(s) available for moxifloxacin and cefuroxime axetil

ArticleYear
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Clinical therapeutics, 1999, Volume: 21, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines

1999
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Respiratory medicine, 2000, Volume: 94, Issue:4

    Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Evaluation; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Sinusitis

2000
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Chest, 2004, Volume: 125, Issue:3

    Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines

2004
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Infection, 2007, Volume: 35, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Ceftriaxone; Cefuroxime; Cross Infection; Drug Therapy, Combination; Endpoint Determination; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome

2007

Other Studies

1 other study(ies) available for moxifloxacin and cefuroxime axetil

ArticleYear
Nosocomial pneumonia - are economical considerations important?
    Infection, 2007, Volume: 35, Issue:6

    Topics: Administration, Oral; Aza Compounds; Ceftriaxone; Cefuroxime; Cross Infection; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Quinolines

2007